What Makes AstraZeneca (AZN) a Strong Growing Company?

2 days ago 2

Soumya Eswaran

Thu, January 15, 2026 astatine 7:21 AM CST 3 min read

Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” fourth-quarter 2025 capitalist letter. It is simply a diversified money that focuses connected semipermanent superior appreciation by investing successful communal stocks of non-U.S. companies, mostly successful the mid and large-cap spectrum. A transcript of the missive tin beryllium downloaded here. In the 4th quarter, the money (Investor Class) delivered a instrumentality of 4.83%, outperforming the benchmark, the MSCI World ex USA Index’s 5.20% gain. Healthcare and financials were the apical show contributors astatine the assemblage level, portion the user staples was the lone detractor. In addition, you tin cheque the Fund’s apical 5 holdings to find its champion picks for 2025.

In its fourth-quarter 2025 capitalist letter, Oakmark International Fund highlighted stocks specified arsenic AstraZeneca PLC (NASDAQ:AZN). AstraZeneca PLC (NASDAQ:AZN) is simply a biopharmaceutical institution that discovers, develops, and manufactures medicine medicines.  On January 14, 2026, AstraZeneca PLC (NASDAQ:AZN) banal closed astatine $96.34 per share. One-month instrumentality of AstraZeneca PLC (NASDAQ:AZN) was 6.32%, and its shares gained 43.98% of their worth implicit the past 52 weeks. AstraZeneca PLC (NASDAQ:AZN) has a marketplace capitalization of $298.709 billion.

Oakmark International Fund stated the pursuing regarding AstraZeneca PLC (NASDAQ:AZN) successful its 4th fourth 2025 capitalist letter:

"AstraZeneca PLC (NASDAQ:AZN) is 1 of the largest pharmaceutical companies successful the world. It researches, develops and commercializes medicine medicines designed to dainty lung and bosom cancers, cardiorenal diseases, respiratory problems and different uncommon diseases. We judge AstraZeneca's robust on-market portfolio and sector-leading late-stage pipeline supply an charismatic maturation profile. Moreover, we judge the institution tin physique connected its agelong way grounds of a productive probe and improvement program, acknowledgment to its innovative civilization and exceptional absorption team. CEO Pascal Soriot is 1 of the industry’s champion executives, and helium has cultivated a heavy seat of talent, a robust decision-making model and a differentiated R&D civilization that should thrust beardown maturation for years to come, successful our view. Recent concerns implicit United States regulations person overshadowed AstraZeneca’s merits and weighed connected the broader pharmaceutical industry. This opened a model for america to acquisition shares of this institution astatine a terms good beneath our estimation of its intrinsic value."

AstraZeneca’s (AZN) Dividend: Resilient, Predictable, and Built connected  Innovation

AstraZeneca’s (AZN) Dividend: Resilient, Predictable, and Built connected Innovation

AstraZeneca PLC (NASDAQ:AZN) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 54 hedge money portfolios held AstraZeneca PLC (NASDAQ:AZN) astatine the extremity of the 3rd quarter, up from 48 successful the erstwhile quarter. While we admit the imaginable of AstraZeneca PLC (NASDAQ:AZN) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.


Read Entire Article